Mengesha YM, Bennett ML. Pustular skin disorders: diagnosis and treatment. Am J Clin Dermatol. 2002;3:389–400.

Article  PubMed  Google Scholar 

Stevens DL, Bisno AL, Chambers HF, Dellinger EP, Goldstein EJC, Gorbach SL, et al. Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the infectious diseases society of America. Clin Infect Dis. 2014;59:147–59.

Article  PubMed  Google Scholar 

Puig L, Choon SE, Gottlieb AB, Marrakchi S, Prinz JC, Romiti R, et al. Generalized pustular psoriasis: a global Delphi consensus on clinical course, diagnosis, treatment goals and disease management. J Eur Acad Dermatol Venereol. 2023;37:737–52.

Article  PubMed  Google Scholar 

Augey F, Renaudier P, Nicolas J-F. Generalized pustular psoriasis (Zumbusch): a French epidemiological survey. Eur J Dermatol. 2006;16:669–73.

PubMed  Google Scholar 

Lee JY, Kang S, Park JS, Jo SJ. Prevalence of psoriasis in Korea: a population-based epidemiological study using the Korean National Health Insurance Database. Ann Dermatol. 2017;29:761–7.

Article  PubMed  Google Scholar 

Löfvendahl S, Norlin JM, Schmitt-Egenolf M. Prevalence and incidence of generalized pustular psoriasis in Sweden: a population-based register study. Br J Dermatol. 2022;186:970–6.

Article  PubMed  Google Scholar 

Duarte GV, Esteves de Carvalho AV, Romiti R, Gaspar A, Gomes de Melo T, Soares CP, et al. Generalized pustular psoriasis in Brazil: a public claims database study. JAAD Int. 2022;6:61–7.

Article  PubMed  Google Scholar 

Jin H, Cho H-H, Kim W-J, Mun J-H, Song M, Kim H-S, et al. Clinical features and course of generalized pustular psoriasis in Korea. J Dermatol. 2015;42:674–8.

Article  PubMed  Google Scholar 

Zelickson BD, Muller SA. Generalized pustular psoriasis. A review of 63 cases. Arch Dermatol. 1991;127:1339–45.

Article  CAS  PubMed  Google Scholar 

•• Navarini AA, Burden AD, Capon F, Mrowietz U, Puig L, Köks S, et al. European consensus statement on phenotypes of pustular psoriasis. J Eur Acad Dermatol Venereol. 2017;31:1792–9. The European Rare and Severe Psoriasis Expert Network (ERASPEN) created diagnostic criteria for generalized pustular psoriasis.

Kromer C, Loewe E, Schaarschmidt M-L, Pinter A, Gerdes S, Herr R, et al. Drug survival in the treatment of generalized pustular psoriasis: a retrospective multicenter study. Dermatol Ther. 2021;34:e14814.

Article  CAS  PubMed  Google Scholar 

Gooderham MJ, Van Voorhees AS, Lebwohl MG. An update on generalized pustular psoriasis. Expert Rev Clin Immunol. 2019;15:907–19.

Article  CAS  PubMed  Google Scholar 

Marrakchi S, Guigue P, Renshaw BR, et al. Interleukin-36-receptor antagonist deficiency and generalized pustular psoriasis. N Engl J Med. 2011;365:620–8.

Article  CAS  PubMed  Google Scholar 

Berki DM, Liu L, Choon S-E, et al. Activating CARD14 mutations are associated with generalized pustular psoriasis but rarely account for familial recurrence in psoriasis vulgaris. J Invest Dermatol. 2015;135:2964–70.

Article  CAS  PubMed  Google Scholar 

Setta-Kaffetzi N, Simpson MA, Navarini AA, et al. AP1S3 mutations are associated with pustular psoriasis and impaired Toll-like receptor 3 trafficking. Am J Hum Genet. 2014;94:790–7.

Article  CAS  PubMed  Google Scholar 

Frey S, Sticht H, Wilsmann-Theis D, et al. Rare loss-of-function mutation in SERPINA3 in generalized pustular psoriasis. J Invest Dermatol. 2020;140:1451-1455.e13.

Article  CAS  PubMed  Google Scholar 

Vergnano M, Mockenhaupt M, Benzian-Olsson N, et al. Loss-of-function myeloperoxidase mutations are associated with increased neutrophil counts and pustular skin disease. Am J Hum Genet. 2020;107:539–43.

Article  CAS  PubMed  Google Scholar 

Lowe NJ, Ridgway HB. Generalized pustular psoriasis precipitated by lithium carbonate. Arch Dermatol. 1978;114:1788–9.

Article  CAS  PubMed  Google Scholar 

Sugiura K, Shoda Y, Akiyama M. Generalized pustular psoriasis triggered by amoxicillin in monozygotic twins with compound heterozygous IL36RN mutations: comment on the article by Navarini et al. J Invest Dermatol. 2014;134:578–9.

Article  CAS  PubMed  Google Scholar 

Duckworth L, Maheshwari MB, Thomson MA. A diagnostic challenge: acute generalized exanthematous pustulosis or pustular psoriasis due to terbinafine. Clin Exp Dermatol. 2012;37:24–7.

Article  CAS  PubMed  Google Scholar 

Chadli Z, Ladhari C, Kerkeni E, Djobbi A, Fredj NB, Chaabane A, et al. Codeine-induced acute generalized exanthematous pustulosis without IL36RN mutations. Pharmacogenomics. 2018;19:889–93.

Article  CAS  PubMed  Google Scholar 

Zheng J, Gao Y, Yi X, Ding Y. A case of ceftriaxone-induced acute generalized exanthematous pustulosis/generalized pustular psoriasis overlap. Case Rep Dermatol. 2018;10:69–75.

Article  PubMed  Google Scholar 

Gammoudi R, Ben Salem C, Boussofara L, Fathallah N, Ghariani N, Slim R, et al. Acute generalized exanthematous pustulosis induced by oxacillin confirmed by patch testing. Contact Dermatitis. 2018;79:108–10.

Article  PubMed  Google Scholar 

Jayasekera P, Parslew R, Al-Sharqi A. A case of tumour necrosis factor-α inhibitor- and rituximab-induced plantar pustular psoriasis that completely resolved with tocilizumab. Br J Dermatol. 2014;171:1546–9.

Article  CAS  PubMed  Google Scholar 

Wu M-C, Lee JY-Y. Generalized flare of pustular psoriasis induced by PEGylated interferon-α2b therapy for chronic hepatitis C. Australas J Dermatol. 2012;53:e69-72.

Article  PubMed  Google Scholar 

Fujita H, Terui T, Hayama K, et al. Japanese guidelines for the management and treatment of generalized pustular psoriasis: the new pathogenesis and treatment of GPP. J Dermatol. 2018;45:1235–70.

Article  PubMed  Google Scholar 

Vyas NS, Charifa A, Desman GT, McNiff JM. Distinguishing pustular psoriasis and acute generalized exanthematous pustulosis on the basis of plasmacytoid dendritic cells and MxA protein. J Cutan Pathol. 2019;46:317–26.

Article  PubMed  Google Scholar 

•• Bachelez H, Choon S-E, Marrakchi S, et al. Trial of spesolimab for generalized pustular psoriasis. N Engl J Med. 2021;385:2431–40. In the Effisayil 1 study, the use ofspesolimab resulted in a higher incidence of pustule clearance than placebo but also resulted in an increased incidence of infection and systemic drug reactions.

Rivera-Díaz R, Daudén E, Carrascosa JM, de la Cueva P, Puig L. Generalized pustular psoriasis: a review on clinical characteristics, diagnosis, and treatment. Dermatol Ther (Heidelb). 2023;13:673–88.

Article  PubMed  Google Scholar 

Krueger J, Puig L, Thaçi D. Treatment options and goals for patients with generalized pustular psoriasis. Am J Clin Dermatol. 2022;23:51–64.

Article  PubMed  Google Scholar 

Sano S, Kubo H, Morishima H, Goto R, Zheng R, Nakagawa H. Guselkumab, a human interleukin-23 monoclonal antibody in Japanese patients with generalized pustular psoriasis and erythrodermic psoriasis: Efficacy and safety analyses of a 52-week, phase 3, multicenter, open-label study. J Dermatol. 2018;45:529–39.

Article  CAS  PubMed  Google Scholar 

Yamanaka K, Okubo Y, Yasuda I, Saito N, Messina I, Morita A. Efficacy and safety of risankizumab in Japanese patients with generalized pustular psoriasis or erythrodermic psoriasis: primary analysis and 180-week follow-up results from the phase 3, multicenter IMMspire study. J Dermatol. 2023;50:195–202.

Article  CAS  PubMed  Google Scholar 

• Robinson A, Van Voorhees AS, Hsu S, Korman NJ, Lebwohl MG, Bebo BF, et al. Treatment of pustular psoriasis: from the Medical Board of the National Psoriasis Foundation. J Am Acad Dermatol. 2012;67:279–88. In 2012, the US Medical Board of the National Psoriasis Foundation provided recommendationsand specifically recommended cyclosporine, acitretin, methotrexate or infliximab as first-line therapy for GPP.

Genovese G, Moltrasio C, Cassano N, Maronese CA, Vena GA, Marzano AV. Pustular psoriasis: from pathophysiology to treatment. Biomedicines. 2021;9:1746.

Article  CAS  PubMed  Google Scholar 

Yu N, Li Y, Ding Y, Shi Y. Combination therapy with acitretin and glycyrrhizin in generalized pustular psoriasis with liver test abnormalities: a case series. Dermatol Ther. 2020;33:e13318.

Article  CAS  PubMed  Google Scholar 

Chen P, Li C, Xue R, Chen H, Tian X, Zeng K, et al. Efficacy and safety of acitretin monotherapy in children with pustular psoriasis: results from 15 cases and a literature review. J Dermatolog Treat. 2018;29:353–63.

Article  CAS  PubMed  Google Scholar 

Wolska H, Jabłonska S, Langner A, Fraczykowska M. Etretinate therapy in generalized pustular psoriasis (Zumbusch type). Immediate and long-term results. Dermatologica. 1985;171:297–304.

CAS  PubMed  Google Scholar 

Kiliç SS, Hacimustafaoğlu M, Celebi S, Karadeniz A, Ildirim I. Low dose cyclosporin A treatment in generalized pustular psoriasis. Pediatr Dermatol. 2001;18:246–8.

Article  PubMed  Google Scholar 

Morita A, Choon SE, Bachelez H, et al. Design of Effisayil™ 2: a randomized, double-blind, placebo-controlled study of spesolimab in preventing flares in patients with generalized pustular psoriasis. Dermatol Ther (Heidelb). 2023;13:347–59.

Article  PubMed  Google Scholar 

Mansouri B, Richards L, Menter A. Treatment of two patients with generalized pustular psoriasis with the interleukin-1β inhibitor gevokizumab. Br J Dermatol. 2015;173:239–41.

Article  CAS  PubMed  Google Scholar 

Skendros P, Papagoras C, Lefaki I, Giatromanolaki A, Kotsianidis I, Speletas M, et al. Successful response in a case of severe pustular psoriasis after interleukin-1β inhibition. Br J Dermatol. 2017;176:212–5.